Publications by authors named "Ana Lako"

19Publications

Regression of multifocoal in transit melanoma metastases after palliative resection of dominant masses and 2 years after treatment with ipilimumab.

J Immunother Cancer 2017 07 18;5(1):61. Epub 2017 Jul 18.

Department of Medical Oncology, Dana Farber Cancer Institute, Brigham and Women's Hospital, and Harvard Medical School, Boston, MA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s40425-017-0259-9DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5514538PMC
July 2017

Mitotic MELK-eIF4B signaling controls protein synthesis and tumor cell survival.

Proc Natl Acad Sci U S A 2016 08 15;113(35):9810-5. Epub 2016 Aug 15.

Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA 02115; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA 02115;

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1073/pnas.1606862113DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5024598PMC
August 2016

MELK is an oncogenic kinase essential for mitotic progression in basal-like breast cancer cells.

Elife 2014 May 20;3:e01763. Epub 2014 May 20.

Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, United States Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, United States

View Article

Download full-text PDF

Source
https://elifesciences.org/articles/01763
Publisher Site
http://dx.doi.org/10.7554/eLife.01763DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4059381PMC
May 2014